Form 4: Microbot Medical Inc. Director Aileen Stockburger Acquires 10,000 Stock Options
SEC Form 4 Filing
Director Aileen Stockburger acquired 10,000 stock options in Microbot Medical Inc. on January 28, 2025.
Summary
- On January 28, 2025, Aileen Stockburger, a director of Microbot Medical Inc., acquired 10,000 stock options.
- The exercise price of these options is $1.93.
- The options become exercisable on December 17, 2025, and expire on January 28, 2035.
- Following this transaction, Ms. Stockburger directly owns 10,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. The acquisition of stock options by a director is generally viewed as a slightly positive sign, but it's a routine event.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership of securities. It is common for directors and officers of publicly traded companies to receive stock options as part of their compensation.
Stakeholder Impact
- The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 01/28/2025 | Date of transaction: Aileen Stockburger acquired 10,000 stock options. |
| 01/29/2025 | Date of signature on the Form 4 filing. |
| 12/17/2025 | Date the stock options become exercisable. |
| 01/28/2035 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.